Skip to main content
Displaying 1261 - 1280 of 1791

Report from the Bureau of Competition

The American Bar Association, Antitrust Section, Spring Meeting 2001
Washington, D.C.Ê
Date
By
Molly S. Boast, Former Director, Bureau of Competition

I. Introduction

I appreciate the opportunity to present this overview of developments at the Bureau of Competition over the last twelve months.(1) I have the distinct honor of succeeding Rich Parker

Washington State Senate: Identity Theft Statement

The Committe on Labor, Commerce and Financial Institutions, Washington State Senate
Olympia, Washington
Date
By
Charles Harwood, Former Deputy Director

Senator Prentice and members of the Committee, I am Charles Harwood, Director of the Northwest Region of the Federal Trade Commission ("FTC" or "Commission").(1) I appreciate the opportunity to

Antitrust Issues in Settlement of Pharmaceutical Patent Disputes

Sixth Annual Health Care Antitrust Forum, Northwestern University School of Law
Chicago, Illinois
Date
By
Thomas B. Leary, Former Commissioner

1. Introduction

I want to thank the Healthcare Antitrust Forum for the invitation to talk about some recent developments in healthcare antitrust at the FTC.(1) An agency representative's usual

Remarks

The First National HIPPA Summit, Grand Hyatt Hotel
Washington, D.C.
Date
By
Sheila F. Anthony, Former Commissioner

I. Introduction

This conference symbolizes a new beginning in the privacy arena. My focus will be on general issues of Internet Privacy and the Federal Trade Commission's role in this area. I hope

EU and U.S. Approaches to International Mergers--Views from the U.S. Federal Trade Commission

Remarks before EC Merger Control 10th Anniversary Conference, The European Commission Directorate General for Competition, International Bar Association, Metropole Hotel
Brussels, Belgium
Date
By
Robert Pitofsky, Former Chairman

It is a delight for me to participate in this panel on Merger Control in an International Context, and to join my enforcement colleagues and friends, Alex Schaub and Joel Klein, in this discussion

Government and the Tech World: Friends or Foes?

Prepared Remarks before the Federalist Society, North Carolina Research Triangle Chapter
Raleigh, North Carolina
Date
By
Orson Swindle, Former Commissioner

Good evening. I'm glad to be here tonight to offer some thoughts as to whether government antitrust enforcement is the "friend or foe" of the tech world.

Is antitrust enforcement is a "friend" or "foe

Antitrust in the Emerging B2B Marketplace

Remarks before Forum for Trust in Online Trade, Princeton Club
New York, N.Y.
Date
By
Orson Swindle, Former Commissioner

It is a pleasure to be with you this afternoon. As is always the case for Federal Trade Commissioners, it is important for me to note that my comments today are my own and in no way represent the

Distribution Law Developments At The Federal Trade Commission

Distribution and Dealer Termination, 21st Anniversary Seminar, Law Journal Seminars
New York, N.Y.
Date
By
Thomas B. Leary, Former Commissioner

The Commission has recently taken two enforcement actions with a potentially significant effect on distribution law. The first is a series of consent agreements involving cooperative advertising in

E-Commerce: The Future of Banking and Financial Services

Remarks before Financial Services Meets E-Commerce: What the Future Holds, The Federalist Society Financial Services and E-Commerce Practice Group and Suffolk University Law School
Date
By
Orson Swindle, Former Commissioner

I am pleased to be here today in Boston - - the cradle of American liberty - - to discuss the impact of technology on the future of e-commerce and the financial services industry. At the outset, I

The Status of Online Privacy

Computer & Communications Industry Association
Date
By
Orson Swindle, Former Commissioner

Thank you for the opportunity this morning to discuss the issue of online privacy.(1) As some of you have no doubt noted, a couple of weeks ago the FTC dramatically reversed course and became an

Riddles and Lessons from the Prescription Drug Wars: Antitrust Implications of Certain Types of Agreements Involving Intellectual Property

Remarks presented before the Attendee of The ABA "Antitrust and Intellectual Property: The Crossroads" Program
San Francisco, California
Date
By
Sheila F. Anthony, Former Commissioner

Good afternoon, I'm very pleased to be here. I'd like to thank Howard and the ABA for inviting me. It's an added bonus that the ABA chose to hold this conference in beautiful San Francisco. I love

Online Privacy Protection Testimony

The U.S. Senate Committee on Commerce, Science, and Transportation
Date
By
Sheila F. Anthony, Former Commissioner

Mr. Chairman and members of the Committee, I am delighted to be here this morning, and I appreciate your holding this hearing to address a topic of great importance to the American people and critical